Elixir Capital Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹39.70Overvalued by 61.08%vs CMP ₹102.00

P/E (9.2) × ROE (5.2%) × BV (₹102.00) × DY (1.23%)

₹127.68Undervalued by 25.18%vs CMP ₹102.00
MoS: +20.1% (Adequate)Confidence: 37/100 (Low)Models: 2 Under, 3 Fair, 3 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹29.5526%Over (-71%)
Graham NumberEarnings₹93.1419%Fair (-8.7%)
Earnings PowerEarnings₹93.2712%Fair (-8.6%)
Net Asset ValueAssets₹101.798%Fair (-0.2%)
EV/EBITDAEnterprise₹223.0010%Under (+118.6%)
Earnings YieldEarnings₹37.808%Over (-62.9%)
ROCE CapitalReturns₹513.1010%Under (+403%)
Revenue MultipleRevenue₹62.156%Over (-39.1%)
Consensus (8 models)₹127.68100%Undervalued
Key Drivers: EPS CAGR -25.6% drags value — could be higher if earnings stabilize. | Wide model spread (₹30–₹513) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -25.6%

*Investments are subject to market risks

Analyst Summary

Elixir Capital Ltd operates in the Finance & Investments segment, NSE: ELIXIR | BSE: 531278, current market price is ₹102.00, market cap is 59.2 Cr.. At a glance, stock P/E is 9.19, ROE is 5.23 %, ROCE is 6.61 %, book value is 102, dividend yield is 1.23 %. The latest intrinsic value estimate is ₹127.68, which is about 25.2% above the current price, so the page currently reads as potentially undervalued rather than fully priced. On operating trend, latest reported sales are about ₹36 Cr versus the prior period change of 4.2%, while latest net profit is about ₹13 Cr with a prior-period change of -39.6%. The 52-week range shown on this page is 144/78.1, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisElixir Capital Ltd. is a Public Limited Listed company incorporated on 30/11/1994 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L6…

This summary is generated from the stock page data available for Elixir Capital Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

49
Elixir Capital Ltd scores 49/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health50/100 · Moderate
ROCE 6.6% WeakROE 5.2% WeakD/E 0.60 ModerateInterest Coverage 0.0x RiskyProfitable 4/5 years Consistent
Smart Money50/100 · Moderate
Promoter holding at 71.2% Stable
Earnings Quality55/100 · Moderate
OPM expanding (23% → 68%) ImprovingWorking capital: 697 days Capital intensive
Quarterly Momentum35/100 · Weak
Revenue (4Q): -43% YoY DecliningProfit (4Q): -91% YoY DecliningOPM: 55.4% (up 16.6% YoY) Margin expansion
Industry Rank55/100 · Moderate
P/E 9.2 vs industry 63.1 Cheaper than peersROCE 6.6% vs industry 10.9% AverageROE 5.2% vs industry 11.6% Below peers3Y sales CAGR: 14% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily.

Share Price and Basic Stock Data

Last Updated: August 25, 2026, 10:03 am

Market Cap 59.2 Cr.
Current Price 102
Intrinsic Value₹127.68
High / Low 144/78.1
Stock P/E9.19
Book Value 102
Dividend Yield1.23 %
ROCE6.61 %
ROE5.23 %
Face Value 10.0
PEG Ratio-0.36

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Elixir Capital Ltd

Competitors

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Elixir Capital Ltd 59.2 Cr. 102 144/78.19.19 1021.23 %6.61 %5.23 % 10.0
Dolat Algotech Ltd 1,306 Cr. 74.2 95.8/65.09.08 64.20.13 %16.3 %12.1 % 1.00
Haryana Capfin Ltd 77.4 Cr. 148 220/1198.63 5640.00 %3.71 %3.09 % 10.0
Ugro Capital Ltd 1,370 Cr. 88.2 193/80.09.79 1830.00 %10.1 %4.64 % 10.0
Chartered Capital & Investment Ltd 82.5 Cr. 274 439/2259.98 5680.00 %2.35 %1.60 % 10.0
Industry Average7,136.06 Cr1,160.4963.073,648.380.43%10.85%11.62%7.17

All Competitor Stocks of Elixir Capital Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 0.08-0.604.756.095.9115.8114.7218.566.04-3.9610.9211.0913.31
Expenses 1.311.511.571.681.622.413.043.003.705.596.676.625.94
Operating Profit -1.23-2.113.184.414.2913.4011.6815.562.34-9.554.254.477.37
OPM % -1,537.50%66.95%72.41%72.59%84.76%79.35%83.84%38.74%38.92%40.31%55.37%
Other Income 0.170.240.340.890.221.200.270.160.22-0.131.170.090.40
Interest 0.330.300.340.400.330.450.430.560.660.380.620.590.58
Depreciation 0.080.100.080.090.080.090.070.090.080.260.110.110.11
Profit before tax -1.47-2.273.104.814.1014.0611.4515.071.82-10.324.693.867.08
Tax % -2.72%16.74%1.61%15.38%22.44%24.32%24.98%25.08%34.62%-18.22%21.54%39.90%23.02%
Net Profit -1.43-2.653.064.083.1910.638.5911.301.19-8.443.692.315.44
EPS in Rs -1.77-3.383.895.394.0713.5410.9414.411.52-10.804.702.956.93

Last Updated: March 3, 2026, 10:06 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 4:45 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 3.8611.704.4512.4110.153.70-0.4019.6224.534.3234.6336.0731.36
Expenses 1.711.812.262.643.763.363.734.615.535.707.2515.3324.82
Operating Profit 2.159.892.199.776.390.34-4.1315.0119.00-1.3827.3820.746.54
OPM % 55.70%84.53%49.21%78.73%62.96%9.19%76.50%77.46%-31.94%79.06%57.50%20.85%
Other Income 0.000.001.540.040.100.060.050.020.030.180.56-0.191.53
Interest 0.060.050.070.130.150.250.190.951.661.131.522.032.17
Depreciation 0.500.470.460.480.470.450.400.410.370.340.340.500.59
Profit before tax 1.599.373.209.205.87-0.30-4.6713.6717.00-2.6726.0818.025.31
Tax % 29.56%29.35%24.38%25.00%28.28%-10.00%10.49%10.53%23.65%28.46%19.63%29.86%
Net Profit 1.116.612.416.904.21-0.21-3.8312.2212.99-3.4320.9612.653.00
EPS in Rs 1.408.432.8911.895.36-0.36-6.6015.7216.54-5.9126.9016.083.78
Dividend Payout % 121.31%20.16%11.74%10.51%23.31%-345.24%-18.93%7.95%7.55%-21.14%4.64%7.77%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)495.50%-63.54%186.31%-38.99%-104.99%-1723.81%419.06%6.30%-126.40%711.08%-39.65%
Change in YoY Net Profit Growth (%)0.00%-559.04%249.85%-225.29%-66.00%-1618.82%2142.87%-412.76%-132.71%837.48%-750.73%

Elixir Capital Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:12%
5 Years:%
3 Years:14%
TTM:-26%
Compounded Profit Growth
10 Years:7%
5 Years:35%
3 Years:0%
TTM:-69%
Stock Price CAGR
10 Years:10%
5 Years:30%
3 Years:39%
1 Year:-11%
Return on Equity
10 Years:16%
5 Years:21%
3 Years:17%
Last Year:18%

Last Updated: September 5, 2025, 3:21 pm

Balance Sheet

Last Updated: August 14, 2026, 6:00 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 5.805.805.805.805.805.805.805.805.805.805.805.80
Reserves 13.4413.9317.6321.1619.7614.7122.8331.4428.0142.6350.9753.28
Borrowings 0.571.951.721.591.221.2417.4417.687.3423.6031.3240.49
Other Liabilities 8.548.3911.2211.6811.7116.7526.7627.7226.3824.3627.5031.55
Total Liabilities 28.3530.0736.3740.2338.4938.5072.8382.6467.5396.39115.59131.12
Fixed Assets 5.675.304.754.874.544.203.933.693.543.263.643.26
CWIP 0.000.000.000.000.000.000.000.000.000.000.000.00
Investments 0.710.830.000.000.009.9112.5111.9311.0712.2417.9620.51
Other Assets 21.9723.9431.6235.3633.9524.3956.3967.0252.9280.8993.99107.35
Total Assets 28.3530.0736.3740.2338.4938.5072.8382.6467.5396.39115.59131.12

Reserves and Borrowings Chart

Cash Flow

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 1.081.27-2.922.022.3212.80-2.024.585.96-17.022.002.83
Cash from Investing Activity + -0.11-2.112.87-1.590.30-9.11-3.350.411.681.79-5.42-0.60
Cash from Financing Activity + -0.611.39-0.19-0.14-1.80-1.3914.24-2.41-12.4613.754.705.74
Net Cash Flow 0.370.55-0.240.290.822.308.872.58-4.82-1.491.297.97
Free Cash Flow 0.781.17-3.081.432.2012.75-2.174.465.78-16.571.132.71
CFO/OP 38%94%-6%58%682%-319%-4%43%-520%-46%39%85%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow2.159.320.248.054.80-0.88-5.37-2.431.32-8.723.78-10.58

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 8.510.000.823.245.751.97-2,646.250.375.2121.122.420.81
Inventory Days -7,418.62
Days Payable
Cash Conversion Cycle 8.510.000.823.245.751.97-10,064.880.375.2121.122.420.81
Working Capital Days 748.91442.371,232.80648.53929.942,434.653,102.50388.25431.071,684.75598.25697.42
ROCE %7.44%38.27%6.27%29.05%16.35%-0.13%-13.23%32.98%29.06%-2.45%36.75%20.07%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 71.29%71.29%71.29%71.29%71.29%71.29%71.29%71.29%71.29%71.29%71.29%71.18%
Public 28.71%28.71%28.71%28.71%28.70%28.71%28.71%28.72%28.72%28.71%28.71%28.82%
No. of Shareholders 3,4693,3253,1873,3973,6974,4814,4904,3464,2274,1023,9533,803

Shareholding Pattern Chart

No. of Shareholders

Elixir Capital Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 16.0726.89-4.2016.5415.72
Diluted EPS (Rs.) 16.0726.89-4.2016.5415.72
Cash EPS (Rs.) 22.6436.70-5.3223.0021.78
Book Value[Excl.RevalReserv]/Share (Rs.) 97.83117.5583.1490.7470.07
Book Value[Incl.RevalReserv]/Share (Rs.) 97.83117.5583.1490.7470.07
Revenue From Operations / Share (Rs.) 60.9456.076.4839.9233.12
PBDIT / Share (Rs.) 35.9647.25-2.0632.8025.90
PBIT / Share (Rs.) 35.1046.67-2.6432.1725.19
PBT / Share (Rs.) 31.0644.94-4.5929.3023.55
Net Profit / Share (Rs.) 21.7836.11-5.9022.3721.07
NP After MI And SOA / Share (Rs.) 16.0726.89-4.2016.5415.72
PBDIT Margin (%) 59.0084.27-31.8282.1678.20
PBIT Margin (%) 57.6083.23-40.7580.5876.05
PBT Margin (%) 50.9580.14-70.8573.4071.10
Net Profit Margin (%) 35.7464.40-91.1156.0463.62
NP After MI And SOA Margin (%) 26.3747.96-64.8041.4247.47
Return on Networth / Equity (%) 16.4232.22-7.2025.7631.86
Return on Capital Employeed (%) 25.4039.68-3.1735.4335.89
Return On Assets (%) 8.0616.19-3.6011.6112.52
Total Debt / Equity (X) 0.550.480.210.470.60
Asset Turnover Ratio (%) 0.330.390.050.290.34
Current Ratio (X) 2.372.522.812.311.91
Quick Ratio (X) 0.700.581.200.950.82
Inventory Turnover Ratio (X) 0.620.000.000.000.00
Dividend Payout Ratio (NP) (%) 10.596.32-40.5410.2911.05
Dividend Payout Ratio (CP) (%) 10.056.19-47.029.9110.58
Earning Retention Ratio (%) 89.4193.68140.5489.7188.95
Cash Earning Retention Ratio (%) 89.9593.81147.0290.0989.42
Interest Coverage Ratio (X) 10.2618.02-1.0611.4415.81
Interest Coverage Ratio (Post Tax) (X) 7.3714.43-2.038.8013.86
Enterprise Value (Cr.) 121.7185.0330.5139.1932.72
EV / Net Operating Revenue (X) 3.442.618.111.691.70
EV / EBITDA (X) 5.833.10-25.502.062.18
MarketCap / Net Operating Revenue (X) 2.211.585.280.950.86
Retention Ratios (%) 89.4093.67140.5489.7088.94
Price / BV (X) 1.381.060.580.590.57
Price / Net Operating Revenue (X) 2.211.585.280.950.86
EarningsYield 0.110.30-0.120.430.54

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

[display_about_company_data title=”About the Company – Qualitative Analysis”]

FAQ

What is the intrinsic value of Elixir Capital Ltd and is it undervalued?

As of 08 September 2026, Elixir Capital Ltd's intrinsic value is ₹127.68, which is 25.18% higher than the current market price of ₹102.00, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (5.23 %), book value (₹102), dividend yield (1.23 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Elixir Capital Ltd?

Elixir Capital Ltd is trading at ₹102.00 as of 08 September 2026, with a FY2026-2027 high of ₹144 and low of ₹78.1. The stock is currently in the middle of its 52-week range. Market cap stands at ₹59.2 Cr..

How does Elixir Capital Ltd's P/E ratio compare to its industry?

Elixir Capital Ltd has a P/E ratio of 9.19, which is below the industry average of 63.07. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Elixir Capital Ltd financially healthy?

Key indicators for Elixir Capital Ltd: ROCE of 6.61 % is on the lower side compared to the industry average of 10.85%; ROE of 5.23 % is below ideal levels (industry average: 11.62%). Dividend yield is 1.23 %.

Is Elixir Capital Ltd profitable and how is the profit trend?

Elixir Capital Ltd reported a net profit of ₹13 Cr in Mar 2025 on revenue of ₹36 Cr. Compared to ₹13 Cr in Mar 2022, the net profit shows a declining trend.

Does Elixir Capital Ltd pay dividends?

Elixir Capital Ltd has a dividend yield of 1.23 % at the current price of ₹102.00. The company pays dividends, though the yield is modest.

Last Updated: August 25, 2026, 10:03 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 531278 | NSE: ELIXIR
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Elixir Capital Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE